XRF ScientificASX:XRF -5.05%99 ROA % is 14.73% as of Dec. 2025, which is 62% above its 10-year median of 9.08. GuruFocus rates ASX:XRF with a GF Score™ of 99/100 and a GF Value™ of A$1.65 (Fairly Valued). The stock has 1 warning sign investors should review. Among 565 Conglomerates companies, XRF Scientific ranks better than 96.46% on this metric.
ROA % is calculated as Net Income divided by its average Total Assets over a certain period of time. XRF Scientific's annualizedNet Income for the quarter that ended in Dec. 2025 was A$10.52 Mil.
XRF Scientific's average Total Assets over the quarter that ended in Dec. 2025 was A$71.41 Mil. Therefore, XRF Scientific's annualized ROA % for the quarter that ended in Dec. 2025 was 14.73%.
The historical rank and industry rank for XRF Scientific's ROA % or its related term are showing as below:
ASX:XRF'
s ROA % Range Over the Past 10 Years
Min: 2.19 Med: 9.08 Max: 15.26
Current: 15.26
During the past 13 years, XRF Scientific's highest ROA % was 15.26%. The lowest was 2.19%. And the median was 9.08%.
ASX:XRF's ROA % is ranked better than 96.46% of 565
companies
in the Conglomerates industry
Industry Median: 2.47
vs ASX:XRF: 15.26
XRF Scientific (ASX:XRF) ROA % Explanation
ROA % measures the rate of return on the total assets (shareholder equity plus liabilities). It measures a firm's efficiency at generating profits from shareholders' equity plus its liabilities. ROA % shows how well a company uses what it has to generate earnings. ROA %s can vary drastically across industries. Therefore, ROA % should not be used to compare companies in different industries. For retailers, a ROA % of higher than 5% is expected. For example, Wal-Mart (WMT) has a ROA % of about 8% as of 2012. For banks, ROA % is close to their interest spread. A banks ROA % is typically well under 2%.
Similar to ROE, ROA % is affected by profit margins and asset turnover. This can be seen from the Du Pont Formula:
Note:
The Net Income data used here is two times the semi-annual (Dec. 2025) net income data. The Revenue data used here is two times the semi-annual (Dec. 2025) revenue data.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Be Aware
Like ROE, ROA % is calculated with only 12 months data. Fluctuations in the company's earnings or business cycles can affect the ratio drastically. It is important to look at the ratio from a long term perspective. ROA % can be affected by events such as stock buyback or issuance, and by goodwill, a company's tax rate and its interest payment. ROA % may not reflect the true earning power of the assets. A more accurate measurement is ROC % (ROC).
Many analysts argue the higher return the better. Buffett states that really high ROA % may indicate vulnerability in the durability of the competitive advantage.
E.g. Raising $43b to take on KO is impossible, but $1.7b to take on Moody's is. Although Moody's ROA % and underlying economics is far superior to Coca Cola, the durability is far weaker because of lower entry cost.
XRF Scientific ROA % Related Terms
XRF Scientific ROA % Historical Data
* Premium members only.
The historical data trend for XRF Scientific's ROA % can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
For the Conglomerates subindustry, XRF Scientific's ROA %, along with its competitors' market caps and ROA % data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
XRF Scientific ROA % vs Conglomerates Industry
For the Conglomerates industry and Industrials sector, XRF Scientific's ROA % distribution charts can be found below:
* The bar in red indicates where XRF Scientific's ROA % falls into.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
In the calculation of annual ROA %, the net income of the last fiscal year and the average total assets over the fiscal year are used. In calculating the quarterly data,
the Net Income data used here is two times the semi-annual (Dec. 2025) net income data.
ROA % is displayed in the 30-year financial page.
XRF Scientific (ASX:XRF) has a ROA % of 14.73% as of Dec. 2025. Return on assets is the ratio of current-period net income to average two-period total assets. View historical data on XRF Scientific and its competitors. This is 62% above median its historical median of 9.08. Over the past decade, XRF Scientific's ROA % has ranged from 2.19 to 15.26. According to the industry distribution chart, XRF Scientific ranks #20 out of 565 companies in the Conglomerates industry, placing it in the top 3.5%.
Is XRF Scientific's ROA % too high?
XRF Scientific's current ROA % of 14.73% is 62% above median its 10-year median of 9.08. Over the past 10 years, this metric has ranged from a low of 2.19 to a high of 15.26. The Conglomerates industry median ROA % is 2.47. XRF Scientific's value of 14.73% is 496.4% above this industry median. Based on the distribution chart, XRF Scientific ranks #20 out of 565 companies in the Conglomerates industry, which is in the top quartile — a strong position relative to peers. Overall, XRF Scientific has a GF Score™ of 99/100 and is considered Fairly Valued, reflecting its overall financial health beyond just this single metric.
How does XRF Scientific's ROA % compare to HON and MMM?
According to the Conglomerates industry distribution chart, XRF Scientific ranks #20 out of 565 companies for ROA %. This places XRF Scientific in the top 4% of its industry — outperforming the majority of peers. The industry median ROA % is 2.47. XRF Scientific's value of 14.73% is 496.4% above this benchmark. Historically, XRF Scientific's own ROA % has ranged from 2.19 to 15.26 over the past decade. While the company's 10-year median is 9.08 vs. the industry median of 2.47, XRF Scientific has consistently been above the industry average. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good ROA % for a Conglomerates company?
The median ROA % among Conglomerates companies is 2.47, based on 565 companies in the industry. Companies in the top quartile (top 25%) have a ROA % significantly above this median, while those in the bottom quartile fall well below. However, ROA % should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. XRF Scientific's current ROA % of 14.73% is 496.4% above the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high ROA % mean?
A high ROA % can signal that a stock is expensive relative to its fundamentals. Return on assets is the ratio of current-period net income to average two-period total assets. View historical data on XRF Scientific and its competitors. For the Conglomerates industry, the median ROA % is 2.47 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. XRF Scientific's current ROA % is 14.73%, which is 62% above median its own 10-year median of 9.08. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is XRF Scientific stock overvalued right now?
Based on GuruFocus' analysis, XRF Scientific (ASX:XRF) is currently considered Fairly Valued. The stock's GF Value™ is A$1.65, compared to a current price of A$1.79 — trading 8.2% above its estimated fair value. The current ROA % is 14.73%, which is 62% above median its 10-year median of 9.08 and 496.4% above the Conglomerates industry median of 2.47. XRF Scientific's overall GF Score™ is 99/100 with 1 warning sign to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is ROA % calculated?
ROA % is calculated from a company's financial statements. For XRF Scientific (ASX:XRF), the current ROA % is 14.73% as of Dec. 2025. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is XRF Scientific (ASX:XRF) Overvalued in 2026?
Based on GuruFocus' analysis, XRF Scientific stock appears to be overvalued.
The current stock price of A$1.79 is trading 8.2% above its estimated GF Value™ of A$1.65.
GuruFocus considers XRF Scientific to be Fairly Valued.
Key valuation signals for ASX:XRF:
ROA %: 14.73% (62% above median its 10-year median of 9.08)
GF Value™: A$1.65 vs. price of A$1.79 (8.2% above fair value)
Industry Position: 496.4% above the Conglomerates median (#20 of 565)
No single metric tells the full story. See the ASX:XRF stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
XRF Scientific Ltd is engaged in the business of manufacturing and marketing precious metal products, specialized chemicals and instruments for the scientific, analytical and mining industries. It operates through the following segments: Capital Equipment, Precious Metals, and Consumables. The company generates maximum revenue from the Capital Equipment segment that Manufactures sample preparation products and analytical instruments. Geographically, it derives a majority of revenue from Australia and also has a presence in Canada and Europe. Some of its product includes Electric Fusion Machines; Fusion Flux; Crushing and Pulverising, platinum lab ware and others.
99GF Score
Get the complete analysis for ASX:XRF
ROA % is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
ASX:XRF has been successfully added to your 
